FDA Drug Application (202292) for FULYZAQ by NAPO PHARMS INC

Back to FDA Applications sponsored by NAPO PHARMS INC

Application Number202292
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameFULYZAQ
Active IngredientCROFELEMER



Back to FDA Applications sponsored by NAPO PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.